Seelos Therapeutics is a biopharmaceutical company focused on the development of product candidates in the areas of urology and rheumatology. Co. has two product candidates : Vitaros, a topically-applied cream formulation of alprostadil for the treatment of erectile dysfunction, which Co. in-licensed from Warner Chilcott Company, Inc.; and RayVa, a topically-applied cream formulation of alprostadil designed to dilate blood vessels for the treatment of Raynaud's Phenomenon, secondary to scleroderma, for which it owns worldwide rights. We show 10 historical shares outstanding datapoints in our coverage of APRI's shares outstanding history.
Understanding the changing numbers of APRI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like APRI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching APRI by allowing them to research APRI shares outstanding history
as well as any other stock in our coverage universe. |
Free APRI Email Alerts:
Video: Shares Outstanding Importance
